149 related articles for article (PubMed ID: 12741454)
1. Expression of Bcl-2 family modulated through p53-dependent pathway in human hepatocellular carcinoma.
Chiu CT; Yeh TS; Hsu JC; Chen MF
Dig Dis Sci; 2003 Apr; 48(4):670-6. PubMed ID: 12741454
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis and expression of the Bcl-2 family of proteins and P53 in human pancreatic ductal adenocarcinoma.
Chen D; Zheng X; Kang D; Yan B; Liu X; Gao Y; Zhang K
Med Princ Pract; 2012; 21(1):68-73. PubMed ID: 22024503
[TBL] [Abstract][Full Text] [Related]
3. Effects of p53 on apoptosis and proliferation of hepatocellular carcinoma cells treated with transcatheter arterial chemoembolization.
Xiao EH; Li JQ; Huang JF
World J Gastroenterol; 2004 Jan; 10(2):190-4. PubMed ID: 14716820
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of proapoptotic proteins Bax and Bcl-X(S) in p53 overexpressing hepatocellular carcinomas.
Beerheide W; Tan YJ; Teng E; Ting AE; Jedpiyawongse A; Srivatanakul P
Biochem Biophys Res Commun; 2000 Jun; 273(1):54-61. PubMed ID: 10873563
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma and markers of apoptosis (bcl-2, bax, bcl-x): prognostic significance.
Garcia EJ; Lawson D; Cotsonis G; Cohen C
Appl Immunohistochem Mol Morphol; 2002 Sep; 10(3):210-7. PubMed ID: 12373145
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
[TBL] [Abstract][Full Text] [Related]
7. Imbalance between cell proliferation and cellular DNA fragmentation in hepatocellular carcinoma.
Wu PC; Lau VK; Fang JW; Lai VC; Lai CL; Lau JY
Liver; 1999 Oct; 19(5):444-51. PubMed ID: 10533805
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma.
Chung YL; Sheu ML; Yen SH
Int J Cancer; 2003 Oct; 107(1):65-73. PubMed ID: 12925958
[TBL] [Abstract][Full Text] [Related]
9. Upregulated expression of Nucleostemin/GNL3 is associated with poor prognosis and Sorafenib Resistance in Hepatocellular Carcinoma.
Hua L; Hu B; Yan D; Liu J; Shen Y; Zhao F; Shen C; Chen B; Cui X
Pathol Res Pract; 2017 Jun; 213(6):688-697. PubMed ID: 28476378
[TBL] [Abstract][Full Text] [Related]
10. RIP1 upregulation promoted tumor progression by activating AKT/Bcl-2/BAX signaling and predicted poor postsurgical prognosis in HCC.
Wang C; Yao B; Xu M; Zheng X
Tumour Biol; 2016 Nov; 37(11):15305-15313. PubMed ID: 27699664
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of apoptosis in synovial sarcoma: correlation with clinicopathologic parameters, cell proliferative activity, and expression of apoptosis-related proteins.
Kawauchi S; Fukuda T; Oda Y; Saito T; Oga A; Takeshita M; Yokoyama K; Chuman H; Iwamoto Y; Sasaki K; Tsuneyoshi M
Mod Pathol; 2000 Jul; 13(7):755-65. PubMed ID: 10912935
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis and cell proliferation: correlation with BCL-2 and P53 oncoprotein expression in human hepatocellular carcinoma.
EI-Emshaty HM; Saad EA; Toson EA; Abdel Malak CA; Gadelhak NA
Hepatogastroenterology; 2014; 61(133):1393-401. PubMed ID: 25436317
[TBL] [Abstract][Full Text] [Related]
13. TIP30 regulates apoptosis-related genes in its apoptotic signal transduction pathway.
Shi M; Zhang X; Wang P; Zhang HW; Zhang BH; Wu MC
World J Gastroenterol; 2005 Jan; 11(2):221-7. PubMed ID: 15633220
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway.
Wan Z; Pan H; Liu S; Zhu J; Qi W; Fu K; Zhao T; Liang J
Oncol Rep; 2015 Mar; 33(3):1560-6. PubMed ID: 25607597
[TBL] [Abstract][Full Text] [Related]
15. Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma.
Jing Z; Nan KJ; Hu ML
World J Gastroenterol; 2005 Apr; 11(13):1910-6. PubMed ID: 15800979
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
[TBL] [Abstract][Full Text] [Related]
17. XPD could suppress growth of HepG2.2.15 and down-regulate the expression of hepatitis B virus x protein through P53 pathway.
Ding H; Xu JJ; Huang Y; Du FT; Zhang JX
Biochem Biophys Res Commun; 2012 Mar; 419(4):761-7. PubMed ID: 22387547
[TBL] [Abstract][Full Text] [Related]
18. Dulxanthone A induces cell cycle arrest and apoptosis via up-regulation of p53 through mitochondrial pathway in HepG2 cells.
Tian Z; Shen J; Moseman AP; Yang Q; Yang J; Xiao P; Wu E; Kohane IS
Int J Cancer; 2008 Jan; 122(1):31-8. PubMed ID: 17847033
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
20. p53 and related proteins in epithelial ovarian cancer.
Sengupta PS; McGown AT; Bajaj V; Blackhall F; Swindell R; Bromley M; Shanks JH; Ward T; Buckley CH; Reynolds K; Slade RJ; Jayson GC
Eur J Cancer; 2000 Dec; 36(18):2317-28. PubMed ID: 11094305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
